Abstract
Introduction
capabilities represents a central facet of metabolic engineering and synthetic biology (31). Owing 68 to the immense selective utility harnessed by the CRISPR/Cas9 system, we hypothesized that it 69 could simplify current protocols for carrying out gene replacement in E. coli, the workhorse of 70 molecular biology and a biotechnological host of interest for the production of biological fuels 71 and chemicals (32-34). In the present study, we outline a simplified strategy for chromosomal 72 gene replacement by coupling the powerful CRISPR/Cas9 system with conventional lambda Red 73 recombineering. We perform preliminary gene replacements to demonstrate the utility of this 74 approach, extensively probe its capacity for generating large chromosomal deletions and 75 insertions, and discuss its advantages over traditional recombineering approaches in the absence 76 of CRISPR/Cas9 selection (3, 10). This method overcomes the dependence on Flippase (Flp) 77 recombination, avoids the creation of chromosomal "scar" sites [i.e., Flp recognition target 78 (FRT) scar sites], is adaptable to multiplexing (27), and can be performed in a shorter period of 79 time compared to previous protocols. Accordingly, CRISPR/Cas9 recombineering simplifies the 80 construction of markerless gene replacement mutants of E. coli and serves as an effective tool for 81 strain optimization, metabolic engineering and synthetic biology. 82
83

Materials and Methods
84
Bacterial strains, plasmids, oligonucleotides, and growth conditions 85 Bacterial strains, plasmids, and oligonucleotides utilized in this work are listed in Table  86 7 Preparation of recombinogenic DNA Red recombineering operon of pKD46 (3). Cells were harvested at an OD 600 of 0.5-0.7, washed 146 three times in ice-cold 10% glycerol, and concentrated approximately 250-fold. Cell-DNA 147 suspensions were transferred to pre-chilled 0.1 cm electroporation cuvettes and electroporated at 148 1.8 kV, 25 μF, and 200 Ω. Cells were recovered in 1 ml SOC medium (36) for 2 hours at 37 ºC 149 and 250 rpm. Outgrowth cultures were serially diluted and 0.002-0.5 μl equivalents were plated 150 onto selective LB agar plates. Selection of pKD46 using ampicillin was not performed following 151 
Results
184
Selection of pKD46-based oligo recombination using the CRISPR/Cas9 system 185 Prior to attempting chromosomal gene replacement using CRISPR/Cas9 selection, we 186 first performed a ssDNA oligo recombination experiment using conventional pKD46-based 187 lambda Red recombineering, as recombination of short oligos is more efficient than 188 recombination of dsDNA PCR products (21, 22). The CRISPR/Cas9 system has recently been 189 coupled to oligo recombineering in E. coli by utilizing a host strain possessing a chromosomal 190 copy of the lambda bet gene expressed from a temperature-sensitive promoter (24). For 191 metabolic and strain engineering, however, it is preferable to express the bet gene in trans, rather 192 than carrying out recombineering in a universal recombination host and subsequently 193 transducing the mutant allele to the desired host background. We therefore investigated the use 194 of a three-plasmid system to couple plasmid-encoded recombineering (pKD46) to the(dbpA::STOP.lead) and lagging (dbpA::STOP.lag) strands of DNA replication whereby 200 successful oligo recombination leads to mutation of the dbpA PAM sequence and introduces two 201 consecutive stop codons within the dbpA ORF, in addition to a unique AseI recognition sequence 202 for mutant screening (Fig. 1a) . Cas9 was targeted to dbpA through construction of 203 pCRISPR::dbpA, which expresses a 30 nt dbpA crRNA. To assess electroporation and oligo 204 recombination in the absence of CRISPR/Cas9 selection, we also constructed pCRISPR::ctrl, 205 expressing a scrambled crRNA devoid of homology to the E. coli genome. Following arabinose 206 induction of lambda Red functions in strain DH5α [pKD46 + pCas9], co-electroporation of 207 pCRISPR::ctrl and a non-recombinogenic control oligo (ctrl.60mer) generated approximately 1.6 208 × 10 9 colony forming units (CFU) μg -1 plasmid DNA, indicating efficient electroporation of 209 pCRISPR::ctrl (Fig. 1b) . Conversely, co-electroporation of pCRISPR::dbpA and ctrl.60mer led 210 to a drastic reduction in electroporation efficiency (greater than three orders of magnitude), 211 owing to CRISPR/Cas9 selection against unmodified host cells. A small proportion of 212 pCRISPR::dbpA transformants (approximately 0.06% compared to pCRISPR::ctrl) were able to 213 survive Cas9 endonuclease attack, presumably due to spontaneous deletion of the dbpA crRNA 214 within pCRISPR::dbpA or mutation of the cas9 coding sequence within pCas9 (24). Having 215 established effective CRISPR/Cas9 selection against unmodified cells, we next utilized our 216 three-plasmid system to select for oligo recombineering mutants through mutation of the 217 CRISPR/Cas9 PAM sequence within the dbpA coding sequence. Co-electroporation of 218 pCRISPR::dbpA with dbpA::STOP.lead or dbpA::STOP.lag oligo led to a 5-and 28-fold 219 increase in electroporation efficiency, respectively, compared to the non-recombinogenic control 220 oligo (ctrl.60mer) through mutation of the dbpA PAM sequence (Fig. 1b) . In line with previous 221 studies of lambda-Red-mediated oligo recombineering in E. coli (21, 37), the oligo targeting the 222 on June 28, 2017 by guest http://aem.asm.org/ Downloaded from lagging strand of DNA replication produced substantially more transformants (greater than five-223 fold) than the leading-strand-targeting-oligo. Using colony PCR followed by AseI digestion, we 224 genotyped a total of 28 and 41 pCRISPR::dbpA transformant colonies generated using the 225 dbpA::STOP.lead and dbpA::STOP.lag oligos, respectively, yielding dbpA recombination 226 efficiencies of 50% for the leading strand oligo and 80% for the lagging strand oligo. Genotyping 227 results from 13 representative colonies generated using the dbpA::STOP.lag oligo is shown in 228 Figure 1c . To further demonstrate the efficacy of CRISPR/Cas9-coupled recombineering, we set 229 out to determine oligo recombineering efficiency in the absence of CRISPR/Cas9 selection. 230
Here, we co-electroporated pCRISPR::ctrl and dbpA::STOP.lag, and screened the resulting 231 transformants using colony PCR and AseI digestion. Of a total of 154 pCRISPR::ctrl 232 transformants screened, two mutant colonies were identified, corresponding to a recombination 233 efficiency of 1.3% (Fig. 1b) . Collectively, the results presented in this section confirm that our 234 three-plasmid system supports efficient CRISPR/Cas9 recombineering using recombinogenic 235 
239
We next aimed to utilize our three-plasmid CRISPR/Cas9 recombineering system to 240 carry out chromosomal gene replacement of dbpA with a markerless dsDNA template. 241
Recombination of dsDNA PCR products requires both lambda Exo and Beta proteins, which are 242 co-expressed from plasmid pKD46 (3). We selected the lacZ′ subunit for gene knock-in, since 243 the resulting PCR cassette is small in length (< 1 kb) and recombinants can be identified directly 244 on June 28, 2017 by guest http://aem.asm.org/ Downloaded from following electroporation using agar plates supplemented with X-Gal for blue-white colony 245 screening. We targeted the same dbpA gene region employed in our oligo recombineering 246 demonstration by employing pCRISPR::dbpA. We also devised two different gene replacement 247 approaches by varying the location of Hn homology arms flanking the chromosomal DSB within 248 the dbpA gene, generating an 8 bp (H0 + H0) or 818 bp deletion (H1 + H2) (Fig. 2a) . To first 249 assess plasmid electroporation efficiency and Cas9-mediated killing of unmodified host cells, we 250 again utilized pCRISPR::ctrl and pCRISPR::dbpA, respectively, along with a 466 bp non-251 recombinogenic PCR product. In a similar manner to the CRISPR/Cas9 oligo recombineering 252 demonstration (Fig. 1b) , co-electroporation of pCRISPR::ctrl and a 466 bp non-recombinogenic 253 PCR product yielded a substantially higher electroporation efficiency (more than three orders of 254 magnitude) compared to co-electroporation of pCRISPR::dbpA with the same control PCR 255 product (Fig. 2b 
277
Since dsDNA gene replacement using CRISPR/Cas9 recombineering proved to be highly 278 efficient (39% and 47% of colonies possessed the target mutation), we sought to establish the 279 performance of this technique with respect to the magnitude of deletion that can be efficiently 280 introduced to the E. coli chromosome. We first examined phenotypic data from the E. coli K-12 281
Keio single gene knockout mutant collection (4) to identify essential genes flanking dbpA that 282 lead to lethality upon gene knockout. We identified a 20.3 kb non-essential chromosomal region, 283 flanked by the essential genes insH-4 and racR (ydaR), which, theoretically, could be deleted 284 without causing cell death. Accordingly, we varied the spacing between chromosomal homology 285 regions (Hn) within PCR primers and held the size of our recombinogenic lacZ′ cassette constant 286 at 560 bp to generate PCR products leading to deletions of various sizes of the E. coli genome. 287
Specifically, we targeted chromosomal deletions of 818 bp (H1 + H2), 2,428 bp (H3 + H4), 288 5,123 bp (H5 + H6), 9,590 bp (H7 + H4), 11,068 bp (H8 + H9), and 19,378 bp (H7 + H9) ( efficiency was found to vary by a factor of 2.7 between the six recombinogenic deletion PCR 296 cassettes assayed (Fig. 3b) . Notably, electroporation efficiencies corresponding to the 2,428 bp 297 and 19,378 bp deletion PCR products were 4% and 34% lower, respectively, than that of the 298 non-recombinogenic control PCR product. Based on data from our preliminary ssDNA and 299 dsDNA CRISPR/Cas9-coupled recombineering experiments ( Fig. 1b and 2b ), a lack of elevation 300 in electroporation efficiency of recombinogenic DNAs relative to the non-recombinogenic 301 control PCR product suggests unsuccessful recombination. Surprisingly, however, target 302 recombination events could be identified for all six chromosomal deletions. Further, 303 recombination efficiency was found to vary dramatically between the chromosomal deletions 304 (recombination efficiencies of 3%-47%; Fig. 3b ). Generally, recombination efficiency decreased 305 with increasing size of chromosomal deletion, yet not in a linear manner across the sizes of 306 deletion assessed. A major drop in recombination efficiency (>80%) was observed by increasing 307 the size of deletion from 818 bp to 2,428 bp. Conversely, recombination efficiency was similar 308 across chromosomal deletions between 2,428 bp and 11,068 bp (recombination efficiencies of 309 8%-11%). Deletion of a 19,378 bp region, comprising a total of 19 chromosomal genes, yielded 310 the lowest recombination efficiency of 3%. Since replacement of 8 bp and 818 bp chromosomal 311 regions with lacZ' using recombineering in the absence of CRISPR/Cas9 selection could bedetected with blue-white colony screening (Fig. 2b) , we also assessed replacement of the 2,428 313 bp chromosomal region with lacZ' using traditional lambda Red recombineering. Whereas 314 recombination efficiency using CRISPR/Cas9 selection was 9%, we were unable to identify a 315 blue recombinant colony amongst the background of unmodified cells for the 2,428 bp deletion 316 in the absence of CRISPR/Cas9 selection (Fig. 3b) . Colony PCR and Sanger sequencing using 317 one blue colony from each of the six chromosomal deletion mutants generated using 318 CRISPR/Cas9-coupled recombineering confirmed successful replacement of the target 319 chromosomal gene(s) with lacZ′ ( Fig. 3c) . plasmid DNA) controls (Fig. 4b) . When co-electroporated with pCRISPR::dbpA, electroporation 339 efficiency between the six various-sized recombinogenic PCR products varied by a factor of 3.6. 340
In a similar manner to the chromosomal deletion PCR cassettes assayed (Fig. 3b) , 341 electroporation efficiencies corresponding to two of the insertion PCR cassettes (1,264 bp and 342 3,000 bp) were lower than that of the control electroporation. Despite this decrease in 343 electroporation efficiency, recombinant colonies could be detected for all six recombinogenic 344 PCR products, where recombination efficiency varied dramatically (1% to 47%) (Fig. 4b) . A 345 substantial decline in recombination efficiency (>90%) resulted from increasing the size of 346 recombinogenic DNA from 560 bp to 1,264 bp. However, recombination efficiency remained 347 relatively constant between PCR products of 1,264 bp to 3,000 bp (1%-4%). We also assessed 348 recombination of the three most recombinogenic PCR products (550 bp, 560 bp, and 2,428 bp) 349 using lambda Red recombineering without CRISPR/Cas9 selection. Whereas PCR products of 350 sizes 550 bp and 560 bp yielded recombination efficiencies of 0.24% and 0.25%, respectively, 351 mutant colonies corresponding to the 1,264 bp insertion could not be identified. Finally, colony 352 PCR and Sanger sequencing of one blue colony from each of the six lacZ′ gene insertion mutants 353 generated using CRISPR/Cas9-coupled recombineering confirmed successful replacement of 354 dbpA with the lacZ′ PCR cassettes of various sizes (Fig. 4c) . pCRISPR co-transformants and can be easily differentiated using PCR screening. In contrast to 385 traditional recombineering protocols for chromosomal gene replacement (3, 9, 10), 386 CRISPR/Cas9 recombineering is simpler, less labor intensive, and can be carried out in a 387 substantially shorter time frame (Fig. 5) . In addition, our approach is easily amendable to 388 multiplexing through the targeting of multiple chromosomal loci (27), and circumvents the use of 389 chromosomal antibiotic markers and Flp-mediated excision for antibiotic marker recycling. 390
Hence, the resulting mutant genome is both markerless and "scar"-less, as no FRT "scar" sites 391 remain following recombination. 392
Our devised three-plasmid approach was shown to allow selection of recombinant cells 393 generated using either ssDNA oligonucleotides (Fig. 1) or heterologous dsDNA PCR products 394 (Fig. 2) . We further probed the performance of the dsDNA gene replacement protocol with 395 respect to the magnitude of deletion and insertion that can be introduced to the host genome. We 396 have shown that deletions up to 19.4 kb, encompassing 19 non-essential chromosomal genes 397 (Fig. 3) , and insertions up to 3 kb (Fig. 4) can be introduced with high recombination efficiency 398 (1%-47%). For comparison, gene replacement using the most recombinogenic substrates assayed 399 in this study produced recombination efficiencies of 0%-0.68% in the absence of CRISPR/Cas9 400 selection, as more challenging gene replacement events could not be detected without 401 incorporation of the CRISPR/Cas9 system ( Fig. 3b and 4b ). When implemented, CRISPR/Cas9 402 selection elevated sensitivity of mutant detection by up to 187-fold (Fig. 1b, 2b, 3b, and 4b) . insertions were assessed independently in this study, where chromosomal deletions were assayed 412 using a comparatively small PCR product (560 bp) and genome insertions were evaluated using 413 only a modest chromosomal deletion (818 bp). Recombination efficiency was found to drop 414 significantly when the magnitude of chromosomal deletion or insertion was increased beyond 415 these levels ( Fig. 3 and 4) . Interestingly, Maresca et al. (38) found similar reductions in gene 416 insertion using substrates ≥ 500 bp, yet recombination was largely unaffected by deletion of 417 bacterial artificial chromosome (BAC) regions ranging from 0.5 kb to 50 kb. This discrepancy 418 may arise from the use of different recipient DNAs (i.e., BACs versus the E. coli chromosome), 419 or through incorporation of CRISPR/Cas9 selection in this study. Nevertheless, our findings 420 imply that replacing a large chromosomal segment (> 818 bp) with a large recombinogenic PCR 421 product (> 560 bp) should yield poor recombination, resulting in an inability to identify and 422 isolate the target mutant. Therefore, gene replacements using our CRISPR/Cas9 recombineering 423 strategy should target either large multi-gene deletions or chromosomal insertion of large PCR 424 products. Owing to the high recombination efficiencies we obtained when deleting large 425 chromosomal segments (3%-8% for deletions of 9.6 kb to 19.4 kb), our approach could find 426 utility in strain optimization and chromosome reduction, whereby genomes are "cleansed" 427 through large-scale deletion of prophages, transposons, and other non-essential host elements 428 (39). In efforts demanding both large chromosome deletion and large heterologous DNA 429 insertion, we recommend utilizing traditional, yet more laborious, lambda Red protocols in the 430 absence of CRISPR/Cas9 selection (3, 10), as rare recombination events can be selected directly 431 via chromosomal antibiotic resistance. Alternatively, increasing the size of homology arms 432 beyond the common 40 nt limit utilized in this study has been shown to enhance recombination 433 (27), which could enable detection of low efficiency events. It has also been reported that 434 homologous recombination varies drastically between genomic loci (40), presumably due to 435 secondary structure and sequence-dependent effects. The chromosomal dbpA locus employed in 436 this study potentially represents a recombination "hot spot", as recombination efficiency of the 437 lagging-strand-targeting oligo was 80%, compared to 65% at the rpsL locus reported by Jiang et 438 al. (24). It is also worth noting that only one of the plasmids employed in our three-plasmid 439 system, pKD46, possesses a low copy, temperature-sensitive plasmid origin (3). Whereas 440 previous recombineering strategies have relied exclusively on such easily curable plasmids (3, 441 10), pCas9 and pCRISPR possess the multi-copy p15A and pBR322 origins, respectively (24), 442 thus requiring specialized procedures for plasmid curing. Fortunately, protocols for curing multi-443 copy plasmids from recombinant E. coli strains using a range of artificial plasmid-curing agents 444
[e.g., acridine orange or sodium dodecyl sulfate (41)] are firmly established (42). 445
Overall, the approach outlined in this study demonstrates that coupling traditional lambda 446
Red recombineering with the powerful CRISPR/Cas9 system leads to simplified construction of 447 markerless chromosomal gene replacement mutants of E. coli. We postulate that the 448 methodology outlined herein will pave the way to novel and more ambitious strain engineering 449 
